Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002638388 | SCV003522154 | uncertain significance | Developmental and epileptic encephalopathy, 25 | 2022-04-06 | criteria provided, single submitter | clinical testing | Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has not been reported in the literature in individuals affected with SLC13A5-related conditions. This variant is present in population databases (rs139005493, gnomAD 0.002%). This sequence change replaces leucine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 450 of the SLC13A5 protein (p.Leu450Ser). |